{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:40:11Z","timestamp":1756320011210,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,1,14]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>We report the case of a man in his 50s who presented with pleural and pericardial effusions, chylous ascites, lymphadenopathy, weight loss and fatigue. Extensive evaluation ruled out malignancy, infection and many autoimmune conditions, but test results were positive for antinuclear antibodies and anti\u2013double-stranded DNA antibodies. A kidney biopsy showed evidence of lupus nephritis (class 5). He ultimately was diagnosed with systemic lupus erythematosus and lupus nephritis. The patient began immunosuppressive treatment, and the manifestations started to resolve. Recognition of systemic lupus erythematosus as the cause of chylous ascites was essential for identifying effective therapy.<\/jats:p>","DOI":"10.1136\/bcr-2024-264415","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:27:44Z","timestamp":1742401664000},"page":"e264415","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Chylous ascites as an initial presentation of lupus nephritis"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1593-3187","authenticated-orcid":false,"given":"Mariya","family":"Pogorelova","sequence":"first","affiliation":[{"name":"Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can M","family":"Sungur","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"2025082711073337000_18.3.e264415.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00573-7"},{"key":"2025082711073337000_18.3.e264415.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260306"},{"key":"2025082711073337000_18.3.e264415.3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14218\/JCTH.2017.00035","article-title":"Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment","volume":"6","author":"Bhardwaj","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"2025082711073337000_18.3.e264415.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05911.x"},{"key":"2025082711073337000_18.3.e264415.5","first-page":"1567","article-title":"Dilated cardiomyopathy associated with chylous ascites","volume":"84","author":"Hurley","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"2025082711073337000_18.3.e264415.6","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/240473","article-title":"Chylous Ascites: Evaluation and Management","volume":"2014","author":"Al-Busafi","year":"2014","journal-title":"ISRN Hepatol"},{"key":"2025082711073337000_18.3.e264415.7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4254\/wjh.v13.i3.300","article-title":"Lymphatic dysfunction in advanced cirrhosis: Contextual perspective and clinical implications","volume":"13","author":"Kumar","year":"2021","journal-title":"World J Hepatol"},{"key":"2025082711073337000_18.3.e264415.8","first-page":"842","article-title":"Chylous ascites in cirrhosis. Retrospective study of 20 cases","volume":"14","author":"Sultan","year":"1990","journal-title":"Gastroenterol Clin Biol"},{"key":"2025082711073337000_18.3.e264415.9","article-title":"Chylous Ascites in Systemic Lupus Erythematosus: A Diagnostic Challenge","volume":"9","author":"Hasan","year":"2017","journal-title":"Cureus"},{"key":"2025082711073337000_18.3.e264415.10","first-page":"1456","article-title":"Gastrointestinal manifestations in systemic lupus erythematosus","volume":"25","author":"Fawzy","year":"2016","journal-title":"Lupus (Los Angel)"},{"key":"2025082711073337000_18.3.e264415.11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023661","article-title":"Clinical characteristics of systemic lupus erythematosus with chylothorax and\/or chylous ascites: An analysis of 15 cases in China","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2025082711073337000_18.3.e264415.12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00519","article-title":"Lymphatic Function in Autoimmune Diseases","volume":"10","author":"Schwartz","year":"2019","journal-title":"Front Immunol"},{"key":"2025082711073337000_18.3.e264415.13","first-page":"781","article-title":"Medical conditions associated with a positive anti-double-stranded deoxyribonucleic acid","volume":"31","author":"Attar","year":"2010","journal-title":"Saudi Med J"},{"key":"2025082711073337000_18.3.e264415.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.002"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-264415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:07:41Z","timestamp":1756318061000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-264415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,19]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bcr-2024-264415"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-264415","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}